High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
scientific article published on 28 May 2015
Author/s
author: Olivier Hermine, Marie-Hélène Delfau-Larue, René-Olivier Casasnovas, Eva Hoster, Catherine Thieblemont, Gilles Salles, Fabrice Jardin, Corinne Haioun, Vincent Ribrag, Josette Briere, Pierre Feugier, Martin Dreyling, Michael Unterhalt, European Mantle Cell Lymphoma Network, Wolfram Klapper
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.